Pharmaceuticals

INVEST IN AFRICA NOW

Set-up your Business in Africa's Key Industrial Zones

Name *

Email *

Phone No. *

Investment Sector

Investment Opportunity

Investment Budget (USD)

How may we assist you?

*Note: Name, Email and Phone Number are mandatory.

I agree to the AFI privacy policy.*

I agree to receive e-communications from AFI.

THANK YOU

Our team will get back to you shortly.

Rwanda's pharmaceutical sector is a hidden gem, poised for explosive growth fueled by a rising domestic market and its strategic position to serve East and Central Africa. Investors can unlock immense potential by entering this nascent market.

$112 Mn

Market Size

0.18%

CAGR

Untapped Potential: Invest in Pharma Sector in BSEZ, Rwanda

Rwanda's pharmaceutical sector presents a compelling opportunity for investors seeking to capitalize on an emerging market with significant growth potential. Despite a small domestic market currently, Rwanda is strategically positioned to become a pharmaceutical hub for East and Central Africa. Data highlights the opportunity: Rwanda boasts a rapidly growing economy with a rising middle class and increasing healthcare expenditure. Furthermore, the government actively prioritizes healthcare development, making significant investments in infrastructure and promoting pharmaceutical imports and local production.

This focus on healthcare, coupled with Rwanda's political stability and improving business environment, creates an attractive landscape for pharmaceutical investors. The potential is further amplified by the rising demand for medicine in East and Central Africa, with a market projected to reach $60 billion USD by 2030. However, Rwanda's pharmaceutical sector currently relies heavily on imported medicines, presenting a gap for local production to fill. Investors can bridge this gap by establishing manufacturing facilities for essential and generic drugs, capitalizing on Rwanda's skilled workforce, government incentives, and strategic location to serve the growing regional market. By investing in Rwanda's pharmaceutical sector, investors can contribute to improving healthcare access within Rwanda and throughout the East and Central African region.